BiotechTube
Home/Aclaris Therapeutics/Douglas J. Manion, M.D.
DJ

Douglas J. Manion, M.D.

President and Chief Executive Officer

Aclaris Therapeutics

Therapeutic Areas

ImmunologyDermatologyRheumatologyGastroenterology

Aclaris Therapeutics Pipeline

DrugIndicationPhase
ATI-450 (zunsemetinib)Rheumatoid ArthritisPhase 2b
ATI-1777Atopic DermatitisPhase 2b
ATI-2138Alopecia AreataPhase 2a
Bosakitug (ATI-045)Atopic DermatitisPhase 2

Leadership Team at Aclaris Therapeutics

DN
Dr. Neal Walker, D.O., M.B.A.
Co-founder and Chair of the Board of Directors
DS
Dr. Stuart D. Shanler, M.D.
Chief Scientific Officer
RA
Robert A. Doody, Jr., J.D.
Chief Business Officer
View full Aclaris Therapeutics profile